Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

羧甲司坦颗粒 - NMPA Drug Approval Details

Approvals/NMPA/Carbocysteine Granules

Approved

化学药品

Carbocysteine Granules

康芝药业股份有限公司🇨🇳 National Medical Products Administration

Approval Date: May 12, 2026
Approval ID: 8n72bM3B0C5
Company: 康芝药业股份有限公司
Type: 化学药品

Approval Details

Approval Id: 8n72bM3B0C5
Approval Number: 国药准字H20264309
Generic Name: 羧甲司坦颗粒
Generic Name En: Carbocysteine Granules
Drug Type: 化学药品
Dosage Form: 颗粒剂
Strength: 每袋含羧甲司坦0.5克
Reg Date: 2026-05-12
Company Name: 康芝药业股份有限公司
Company Address: 海南省海口国家高新技术产业开发区药谷工业园药谷三路6号
Production Company Name: 康芝药业股份有限公司
Production Company Address: 海南省海口国家高新技术产业开发区药谷工业园药谷三路6号
Company Detail Path: /organization/honz-pharmaceutical-co-ltd
Production Company Detail Path: /organization/honz-pharmaceutical-co-ltd

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

May 12, 2026

Approval ID

8n72bM3B0C5

Type

化学药品

Back to NMPA Approvals